Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure

Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure

OBJECTIVE: To assess the hemodynamic and vasodilating effects of milrinone lactate (ML) in patients with dilated cardiomyopathy (DCM) and New York Heart Association (NYHA) class III and IV heart failure. METHODS: Twenty patients with DCM and NYHA class III and IV heart failure were studied. The hemo...

Full description

Bibliographic Details
Main Authors:	Edson Antonio Bregagnollo, Adjair Humberto Fortes, Antonio Carlos Cicogna
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Cardiologia (SBC) 1999-02-01
Series:	Arquivos Brasileiros de Cardiologia
Subjects:	heart failure inotropic agents milrinone
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X1999000200003

Similar Items

Use of Inotropic Agents in Treatment of Systolic Heart Failure
by: Sohaib Tariq, et al.
Published: (2015-12-01)

Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial
by: Pietro Di Santo, et al.
Published: (2021-08-01)

Properties and synthesis of milrinone
by: Mirković Jelena M., et al.
Published: (2013-01-01)

Heart Failure Treated with Low-dose Milrinone in a Full-term Newborn
by: S. Šebková, et al.
Published: (2012-01-01)

Synthesis and Positive Inotropic Activity of [1,2,4]Triazolo[4,3-a] Quinoxaline Derivatives Bearing Substituted Benzylpiperazine and Benzoylpiperazine Moieties
by: Xue-Kun Liu, et al.
Published: (2017-02-01)

Association of preoperative duration of inotropy on prevalence of right ventricular failure following LVAD implantation
by: Mina M. Benjamin, et al.
Published: (2020-08-01)

Impact of the perioperative inotropic support in grown-up congenital heart patients undergoing cardiac surgery: a propensity score adjusted analysis
by: Philippe Mauriat, et al.
Published: (2020-07-01)

Milrinone infusion: A therapeutic option in coronary vasospasm after primary percutaneous transluminal coronary angioplasty
by: Singh Amarpal, et al.
Published: (2009-01-01)

Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension
by: Mai Mohsen Abdelazziz, et al.
Published: (2019-01-01)

Long‐term administration of intravenous inotropes in advanced heart failure
by: Piero Gentile, et al.
Published: (2021-10-01)

Enhancing Oocyte Competence With Milrinone as a Phosphodiesterase 3A Inhibitor to Improve the Development of Porcine Cloned Embryos
by: Pantu Kumar Roy, et al.
Published: (2021-04-01)

Effect of the adjuvant milrinone therapy on cardiac function, myocardial remodeling and RAAS system activity in patients with chronic heart failure
by: Jing Chen
Published: (2017-09-01)

Effects of Milrinone continuous intravenous infusion on global cerebral oxygenation and cerebral vasospasm after cerebral aneurysm surgical clipping
by: Mohamed A. Ghanem, et al.
Published: (2014-01-01)

Effects of Widespread Inotrope Use in Acute Heart Failure Patients
by: Jeehoon Kang, et al.
Published: (2018-10-01)

Milrinone-Induced Pharmacological Preconditioning in Cardioprotection: Hints for a Role of Mitochondrial Mechanisms
by: Annika Raupach, et al.
Published: (2019-04-01)

Myocardial inotropic reserve: An old twist that constitutes a reliable index in the modern era of heart failure
by: Fragkiskos Parthenakis, et al.
Published: (2016-09-01)

Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts
by: Matsumoto Shuhei, et al.
Published: (2012-01-01)

Randomized comparative study of intravenous infusion of three different fixed doses of milrinone in pediatric patients with pulmonary hypertension undergoing open heart surgery
by: Neeraj Kumar Barnwal, et al.
Published: (2017-01-01)

Does glucagon have a positive inotropic effect in the human heart?
by: Jesus Hernández-Cascales
Published: (2018-11-01)

Effectiveness of milrinone for cardiogenic shock due to massive pulmonary aspiration: a case report
by: Jeong Heon Park, et al.
Published: (2014-06-01)

Milrinone in Enterovirus 71 Brain Stem Encephalitis
by: SHIH-MIN eWANG, et al.
Published: (2016-03-01)

Intravenous administration of Milrinone, as an alternative approach to treat vasospasm in subarachnoid hemorrhage: A case report of transcranial Doppler monitoring
by: Alex Goes Santos‐Teles, et al.
Published: (2019-04-01)

Symmetrical peripheral gangrene in sepsis after treatment with inotropes
by: Jiin-Ling Jiang, et al.
Published: (2017-01-01)

Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer’s Disease in an APP/PS1 Mouse Model
by: Chen Q, et al.
Published: (2021-06-01)

Effect of milrinone on the inflammatory response and NF-kB activation in renal ischemia-reperfusion injury in mice
by: Hong Soo Jung, et al.
Published: (2014-02-01)

Effect of milrinone on the cardiac function and N-terminal pro-brain natriuretic peptide levels in patients with senile refractory heart failure
by: Jiao-Na Wei1, et al.
Published: (2017-06-01)

Postpartum gangrene of three limbs complicating inotrope therapy: A case report
by: Ahmed S. El-agwany, et al.
Published: (2014-10-01)

The effect of milrinone on mortality in adult patients who underwent CABG surgery: a systematic review of randomized clinical trials with a meta-analysis and trial sequential analysis
by: Yu-shan Ren, et al.
Published: (2020-07-01)

Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality
by: Dorthe Viemose Nielsen, et al.
Published: (2018-02-01)

Intravenous Milrinone Salvage Therapy in Acute Internal Carotid Artery Occlusion: Case Report
by: Hosam Al-Jehani, et al.
Published: (2019-01-01)

The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1): study protocol and review of literature
by: Afif EL-Khuffash, et al.
Published: (2018-12-01)

Retracted: Effects of cardiac resynchronization therapy in patients with inotrope‐dependent class IV end‐stage heart failure
by: Ikutaro Nakajima, et al.
Published: (2013-12-01)

Inotropic and cardioprotective effects of Daucus carota Linn. on isoproterenol-induced myocardial infarction
by: Pavan Kumar, et al.
Published: (2008-12-01)

Catecholamine induced cardiomyopathy in pheochromocytoma
by: Ron Thomas Varghese, et al.
Published: (2013-01-01)

Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series
by: Sepideh Taghavi, et al.
Published: (2020-12-01)

Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol
by: Laura Caroline Tavares Hastenteufel, et al.

Peri-operative Inotrope Use in Off Pump Coronary Artery Bypass Graft Surgeries
by: Nidheesh Chooriyil, et al.
Published: (2017-12-01)

Charakterisierung negativ inotroper Substanzen nach Myokardischämie
by: Stangl, Verena
Published: (2002)

Vasoactive–Inotropic Score as an Early Predictor of Mortality in Adult Patients with Sepsis
by: Juhyun Song, et al.
Published: (2021-01-01)

Cardiac Inotropes Offer Protection of Renal Function in Patients with Kidney Transplantation
by: Ning Guo, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_jjp2qo7gnm8qjqhr4ta5jjns1g